Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aducanumab
3
×
boston blog main
3
×
boston top stories
3
×
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
affordable care act
alzheimer's disease
biogen
biotech
celgene
clinical trials
deals
gilead sciences
johnson & johnson
nash
ngm biopharmaceuticals
nonalcoholic steatohepatitis
What
bio
drug
news
3
×
roundup
biogen
biogen’s
nash
week
adu
aducanumab
alzheimer’s
amyloid
angst
approval
approved
bagged
beats
bids
billions
biopharmaceutical
brammer
companies
complicated
convo
depression
dire
earlier
effects
failure
failures
felt
good
group
heart
help
littered
lost
medical
need
new
Language
Current search:
aducanumab
×
news
×
" boston blog main "
×
" boston top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More